Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Neuropharmacology
|
May 15, 2018
Evaluation of reinforcing and aversive effects of voluntary Δ<sup>9</sup>-tetrahydrocannabinol ingestion in rats
Daniel G Barrus, Timothy W Lefever, Jenny L Wiley
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 19, 2020
Sex, species and age: Effects of rodent demographics on the pharmacology of ∆<sup>9</sup>-tetrahydrocanabinol
Jenny L Wiley, Daniel G Barrus, Charlotte E Farquhar, et al.
Substance Abuse : Research and Treatment
|
May 5, 2017
Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice
Timothy W Lefever, Julie A Marusich, Brian F Thomas, et al.
Methods Report (RTI Press)
|
January 28, 2017
Tasty THC: Promises and Challenges of Cannabis Edibles
Daniel G Barrus, Kristen L Capogrossi, Sheryl C Cates, et al.
Journal of Medicinal Chemistry
|
April 8, 2025
Development of Squaramides as Allosteric Modulators of the CB<sub>1</sub> Receptor: Synthesis, Computational Studies, Biological Characterization, and Effects against Cocaine-Induced Behavioral Sensitization and Reinstatement in Rats
Thuy Nguyen, Ann M Decker, Daniel G Barrus, et al.
Pharmacology Research & Perspectives
|
January 18, 2022
Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018
David B Finlay, Thuy Nguyen, Thomas F Gamage, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 28, 2024
Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice
Jenny L Wiley, Julie A Marusich, Bruce E Blough, et al.
Journal of Medicinal Chemistry
|
March 27, 2025
Development of Diphenyl-1,2,4-Oxadiazole Analogues as Allosteric Modulators of the RXFP3 Receptor: Evaluation of Importance of the N-Substituted-2-Pyrrolidone Moiety in RLX-33
Dongliang Guan, Hetti Handi Chaminda Lakmal, Brooke N Bender, et al.
Pharmacology, Biochemistry, and Behavior
|
April 6, 2020
In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018
Thomas F Gamage, Daniel G Barrus, Richard C Kevin, et al.
Journal of the American Chemical Society
|
June 14, 2023
Axially Chiral Cannabinoids: Design, Synthesis, and Cannabinoid Receptor Affinity
Sara E Kearney, Anghelo J Gangano, Daniel G Barrus, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Neuropharmacology
|
May 15, 2018
Evaluation of reinforcing and aversive effects of voluntary Δ<sup>9</sup>-tetrahydrocannabinol ingestion in rats
Daniel G Barrus, Timothy W Lefever, Jenny L Wiley
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 19, 2020
Sex, species and age: Effects of rodent demographics on the pharmacology of ∆<sup>9</sup>-tetrahydrocanabinol
Jenny L Wiley, Daniel G Barrus, Charlotte E Farquhar, et al.
Substance Abuse : Research and Treatment
|
May 5, 2017
Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice
Timothy W Lefever, Julie A Marusich, Brian F Thomas, et al.
Methods Report (RTI Press)
|
January 28, 2017
Tasty THC: Promises and Challenges of Cannabis Edibles
Daniel G Barrus, Kristen L Capogrossi, Sheryl C Cates, et al.
Journal of Medicinal Chemistry
|
April 8, 2025
Development of Squaramides as Allosteric Modulators of the CB<sub>1</sub> Receptor: Synthesis, Computational Studies, Biological Characterization, and Effects against Cocaine-Induced Behavioral Sensitization and Reinstatement in Rats
Thuy Nguyen, Ann M Decker, Daniel G Barrus, et al.
Pharmacology Research & Perspectives
|
January 18, 2022
Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018
David B Finlay, Thuy Nguyen, Thomas F Gamage, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 28, 2024
Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice
Jenny L Wiley, Julie A Marusich, Bruce E Blough, et al.
Journal of Medicinal Chemistry
|
March 27, 2025
Development of Diphenyl-1,2,4-Oxadiazole Analogues as Allosteric Modulators of the RXFP3 Receptor: Evaluation of Importance of the N-Substituted-2-Pyrrolidone Moiety in RLX-33
Dongliang Guan, Hetti Handi Chaminda Lakmal, Brooke N Bender, et al.
Pharmacology, Biochemistry, and Behavior
|
April 6, 2020
In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018
Thomas F Gamage, Daniel G Barrus, Richard C Kevin, et al.
Journal of the American Chemical Society
|
June 14, 2023
Axially Chiral Cannabinoids: Design, Synthesis, and Cannabinoid Receptor Affinity
Sara E Kearney, Anghelo J Gangano, Daniel G Barrus, et al.
Page
of 1